Galaxy Securities reported on October 24 that Zhejiang Jingxin Pharmaceutical (002020.SZ) released its third-quarter report. The company achieved revenue of 3.209 billion yuan in the first three quarters, a year-on-year increase of 9.68%; net income attributable to the shareholders of the listed company was 0.575 billion yuan, a year-on-year increase of 21.66%; net income after deducting non-recurring gains and losses was 0.494 billion yuan, a year-on-year increase of 13.16%; basic earnings per share was 0.67 yuan per share.
English
Back
- Markets
- Features
- News
- Community
- Learn
- Help Center
- About
- Offers & Rewards
- Welcome RewardsOpen an account and get up to HKD1800!
- Enjoy limited-time 5%+5% returns on Cash PlusInvest any amount and enjoy a 5% average return on Cash Plus + 5% welcome reward
- Join Futubull Membership ProgramUnlock 11 Premier Benefits
- Referral PromotionBring a friend and collect up to HK$600 in rewards
- Learn PremiumAnalyst 1V1 online teaching
- Stock TransferSwitch to Futu and get up to HK$7,000 in rewards
- English
- 繁體中文
- 简体中文
- Dark
- Light
- Headlines
- Zhejiang Jingxin Pharmaceutical (002020.SZ): The net income for the first three quarters was 0.575 billion yuan, a year-on-year increase of 21.66%.
京新药业(002020.SZ):前三季度净利润5.75亿元,同比增长21.66%
Zhejiang Jingxin Pharmaceutical (002020.SZ): The net income for the first three quarters was 0.575 billion yuan, a year-on-year increase of 21.66%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
07:35
Zhang Jun, chief economist at Galaxy Securities, believes that the People's Bank of China is expected to take greater measures to cut interest rates and reserve requirements next year, with a potential total reduction of 40-60 basis points in the policy interest rate throughout the year, guiding the 5-year LPR down by 60-100 basis points, and a possible total reserve requirement cut of 150-250 basis points for the year.
07:29
Analyst: Currently, there is not much need for the central bank to cut interest rates again.
07:28
The chief economist of huaxi, Liu Yu, stated that the bond bull market is expected to continue in the coming year. Although there is a phenomenon of 'running ahead' in the market as the year-end approaches, it is still necessary to actively allocate cost-effective bond assets.
Huaxi-1.13%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.